As inflation rate is near the upper limit of the comfort zone, experts rule out rate cuts anytime soon
'The domestic scenario is much better than earlier, demonstrated in the March quarter earnings.'
'We have seen a host of businesses across sectors generate economic value and wealth for investors.'
A section of analysts feel now may not be a bad time to buy select PSBs.
Analysts mostly prefer domestic plays beside select films with foreign exposure.
The sentiment around Indian equities remains positive and unchanged.
Bankruptcy Code will consolidate existing laws related to liquidation and sick industries
'The focus is more on the outlook for global growth'.
While the Budget might have been a sentiment booster for the sector, firms with market dominance emerge as favourites.
The management, however, is a bit wary about near-term performance.
Natco Pharma, Wockhardt and Marksans have rallied between 50 and 70 per cent in the year till date.
Almost a third of the company's capex was stuck in this project
Godrej Properties, is on the horizon as it unlocks value in its high-value Bandra-Kurla Complex (BKC) project.
Given its network and fleet, it has garnered the highest share of passenger growth.
The reason is believed to be a 19% increase in interest cost.
Brokerages have cut the company's FY16 earnings estimates between 16% and 29% with target prices too coming down to the Rs 700-800 band
FIIs are looking at the long-term story and initiatives of Indian pharma companies to transform themselves into global entities.
Telcos have indicated that rates will have to be raised, as higher volumes alone will not suffice to meet the higher costs.
The challenge of merging Ranbaxy into the company has not been factored in.
It was a year of big gains for equity investors.
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances